Previous studies used the first generation Septin 9 detection kit (Epi proColon 1.0) and found Septin 9 positivity in 9% of healthy subjects and 73% of CRC patients [14]–[17]. This evidence concerns the gene SEPTIN9 and colorectal carcinoma.